Leishmaniasis in humans: drug or vaccine therapy?
M Ghorbani, R Farhoudi - Drug design, development and therapy, 2017 - Taylor & Francis
Leishmania is an obligate intracellular pathogen that invades phagocytic host cells.
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …
Approximately 30 different species of Phlebotomine sand flies can transmit this parasite …
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
Visceral leishmaniasis (VL) is a systemic protozoan disease that is transmitted by
phlebotomine sandflies. Poor and neglected populations in East Africa and the Indian sub …
phlebotomine sandflies. Poor and neglected populations in East Africa and the Indian sub …
Advances in leishmaniasis
HW Murray, JD Berman, CR Davies, NG Saravia - The Lancet, 2005 - thelancet.com
Governed by parasite and host factors and immunoinflammatory responses, the clinical
spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions) …
spectrum of leishmaniasis encompasses subclinical (inapparent), localised (skin lesions) …
Kinetoplastids: related protozoan pathogens, different diseases
K Stuart, R Brun, S Croft, A Fairlamb… - The Journal of …, 2008 - Am Soc Clin Investig
Kinetoplastids are a group of flagellated protozoans that include the species Trypanosoma
and Leishmania, which are human pathogens with devastating health and economic effects …
and Leishmania, which are human pathogens with devastating health and economic effects …
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda
Visceral leishmaniasis is common in less developed countries, with an estimated 500 000
new cases each year. Because of the diversity of epidemiological situations, no single …
new cases each year. Because of the diversity of epidemiological situations, no single …
Vaccines for visceral leishmaniasis: A review
K Jain, NK Jain - Journal of immunological methods, 2015 - Elsevier
Visceral leishmaniasis, which is also known as Kala-Azar, is one of the most severely
neglected tropical diseases recognized by the World Health Organization (WHO). The threat …
neglected tropical diseases recognized by the World Health Organization (WHO). The threat …
Vaccines to prevent leishmaniasis
R Kumar, C Engwerda - Clinical & translational immunology, 2014 - Wiley Online Library
Leishmaniasis is a parasitic disease that encompasses a range of clinical manifestations
affecting people in tropical and subtropical regions of the world. Epidemiological and …
affecting people in tropical and subtropical regions of the world. Epidemiological and …
Leishmaniasis: new approaches to disease control
Leishmaniasis: new approaches to disease control | The BMJ Skip to main content Intended
for healthcare professionals Access provided by Google Indexer Subscribe My Account My …
for healthcare professionals Access provided by Google Indexer Subscribe My Account My …
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection
G Volpedo, RH Huston, EA Holcomb… - Expert review of …, 2021 - Taylor & Francis
Introduction Leishmaniasis is a major public health problem and the second most lethal
parasitic disease in the world due to the lack of effective treatments and vaccines. Even …
parasitic disease in the world due to the lack of effective treatments and vaccines. Even …
Second-generation vaccines against leishmaniasis
RN Coler, SG Reed - Trends in parasitology, 2005 - cell.com
Several species of Leishmania cause human diseases that range from self-healing
cutaneous lesions to fatal visceral leishmaniasis, mucosal leishmaniasis and diffuse …
cutaneous lesions to fatal visceral leishmaniasis, mucosal leishmaniasis and diffuse …